Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nada M. Alkhani"'
Autor:
Ahmed A. Alrashed, Tahir M. Khan, Noara K. Alhusseini, Syed Mohammed Basheeruddin Asdaq, Mushira Enani, Bandar Alosaimi, Nada M. Alkhani, Yahya Mohzari, Maram M. Alghalbi, Wafa Alfahad, Mona A. Alanazi, Asma S. Albujaidya, Amal Ben-Akresh, Malak Almutairi, Ivo Abraham, Ahmad Alamer
Publikováno v:
Journal of Infection and Public Health, Vol 14, Iss 6, Pp 726-733 (2021)
Background: The uncertainty about COVID-19 outcomes in angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) users continues with contradictory findings. This study aimed to determine the effect of ACEI/ARB use in patien
Externí odkaz:
https://doaj.org/article/dcce0e10a1b8427ab627390e083e20c5
Autor:
Yahya Mohzari, Mushira Enani, Asma S. Albujaidya, Bandar Alosaimi, Nada M. Alkhani, Ahmed A. Alrashed, Mona A. Alanazi, Amal Ben-Akresh, Ahmad Alamer, Tahir Mehmood Khan, Syed Mohammed Basheeruddin Asdaq, Ivo Abraham, Malak Almutairi, Wafa Alfahad, Maram M. Alghalbi, Noara Alhusseini
Publikováno v:
Journal of Infection and Public Health, Vol 14, Iss 6, Pp 726-733 (2021)
Journal of Infection and Public Health
Journal of Infection and Public Health
Background The uncertainty about COVID-19 outcomes in angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) users continues with contradictory findings. This study aimed to determine the effect of ACEI/ARB use in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b701adff8142b4fd727d1c2a485984cc
http://www.sciencedirect.com/science/article/pii/S1876034121000691
http://www.sciencedirect.com/science/article/pii/S1876034121000691
Autor:
Asma S. Albujaidya, Mushira Enani, Yahya Mohzari, Syed Mohammed Basheeruddin Asdaq, Ahmad Alamer, Ahmed A. Alrashed, Bandar Alosaimi, Malak Almutairi, Mona A. Alanazi, Ivo Abraham, Tahir Mehmood Khan, Nada M. Alkhani, Wafa Alfahad, Noara Alhusseini, Amal Ben-Akresh, Maram M. Alghalbi
Background: The uncertainty about COVID-19 outcomes in angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) users continues with contradictory findings. The aim of this study was to determine the effect of ACEI/ARB use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26bad80780b6e8224b783bb7f4a5cec8
https://doi.org/10.21203/rs.3.rs-113824/v1
https://doi.org/10.21203/rs.3.rs-113824/v1
Autor:
Ahmed A. Alrashed, Tahir M. Khan, Noara K. Alhusseini, Syed Mohammed Basheeruddin Asdaq, Mushira Enani, Bandar Alosaimi, Nada M. Alkhani, Yahya Mohzari, Maram M. Alghalbi, Wafa Alfahad, Mona A. Alanazi, Amal Ben-Akresh, Malak Almutairi, Ivo Abraham, Ahmad Alamer
The uncertainty about COVID-19 outcomes in angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) users continues with contradictory findings. The aim of this study was to determine the effect of ACEI/ARB use in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18ba1dd9ce774c20f0f0966ec7755815
https://doi.org/10.21203/rs.3.rs-76839/v1
https://doi.org/10.21203/rs.3.rs-76839/v1